Focus Partners Wealth Buys New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Focus Partners Wealth bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 15,826 shares of the medical instruments supplier's stock, valued at approximately $300,000.

Several other institutional investors also recently bought and sold shares of the business. Treasurer of the State of North Carolina increased its holdings in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after buying an additional 560 shares during the period. UMB Bank n.a. increased its holdings in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the period. Blue Trust Inc. increased its holdings in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock valued at $137,000 after buying an additional 707 shares during the period. Quarry LP increased its holdings in DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after buying an additional 780 shares during the period. Finally, Federated Hermes Inc. increased its holdings in DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after buying an additional 915 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

XRAY has been the topic of several research reports. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a report on Tuesday, April 15th. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Mizuho cut their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Finally, Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $20.36.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.50% of the company's stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded up $0.87 during trading hours on Tuesday, reaching $16.34. 2,368,514 shares of the company traded hands, compared to its average volume of 2,966,347. The stock has a market capitalization of $3.26 billion, a P/E ratio of -7.89, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $28.25. The business has a fifty day moving average price of $14.48 and a 200-day moving average price of $17.06.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.42 earnings per share. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.92%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.